CONBA(SH:600572) Ge Long Hui·2025-11-14 08:06Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun exporting [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the Belt and Road Initiative, to expand its international market [1]